BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19995130)

  • 1. GCP II inhibition rescues neurons from gp120IIIB-induced neurotoxicity.
    Thomas AG; Bodner A; Ghadge G; Roos RP; Slusher BS
    J Neurovirol; 2009 Sep; 15(5-6):449-57. PubMed ID: 19995130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3.
    Berent-Spillson A; Robinson AM; Golovoy D; Slusher B; Rojas C; Russell JW
    J Neurochem; 2004 Apr; 89(1):90-9. PubMed ID: 15030392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection afforded by NAAG and NAALADase inhibition requires glial cells and metabotropic glutamate receptor activation.
    Thomas AG; Olkowski JL; Slusher BS
    Eur J Pharmacol; 2001 Aug; 426(1-2):35-8. PubMed ID: 11525768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of NAALADase by 2-PMPA attenuates cocaine-induced relapse in rats: a NAAG-mGluR2/3-mediated mechanism.
    Xi ZX; Li X; Peng XQ; Li J; Chun L; Gardner EL; Thomas AG; Slusher BS; Ashby CR
    J Neurochem; 2010 Jan; 112(2):564-76. PubMed ID: 19895667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection mediated by glutamate carboxypeptidase II (NAALADase) inhibition requires TGF-beta.
    Thomas AG; Liu W; Olkowski JL; Tang Z; Lin Q; Lu XC; Slusher BS
    Eur J Pharmacol; 2001 Oct; 430(1):33-40. PubMed ID: 11698060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG).
    Hicks C; Gregg RA; Nayak SU; Cannella LA; Schena GJ; Tallarida CS; Reitz AB; Smith GR; Rawls SM
    Psychopharmacology (Berl); 2017 Jun; 234(11):1671-1681. PubMed ID: 28251297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetyl-aspartyl-glutamate and inhibition of glutamate carboxypeptidases protects against soman-induced neuropathology.
    Guo H; Liu J; Van Shura K; Chen H; Flora MN; Myers TM; McDonough JH; McCabe JT
    Neurotoxicology; 2015 May; 48():180-91. PubMed ID: 25825357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Existence of glia mitigated ketamine-induced neurotoxicity in neuron-glia mixed cultures of neonatal rat cortex and the glia-mediated protective effect of 2-PMPA.
    Zuo D; Wang C; Li Z; Lin L; Duan Z; Qi H; Li L; Sun F; Wu Y
    Neurotoxicology; 2014 Sep; 44():218-30. PubMed ID: 24931484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of N-acetylaspartylglutamate in a neonatal rat model of hypoxia-ischemia.
    Cai Z; Lin S; Rhodes PG
    Eur J Pharmacol; 2002 Feb; 437(3):139-45. PubMed ID: 11890901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration.
    Rais R; Wozniak K; Wu Y; Niwa M; Stathis M; Alt J; Giroux M; Sawa A; Rojas C; Slusher BS
    PLoS One; 2015; 10(7):e0131861. PubMed ID: 26151906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of NAAG peptidase inhibitor 2-PMPA in model chronic pain - relation to brain concentration.
    Nagel J; Belozertseva I; Greco S; Kashkin V; Malyshkin A; Jirgensons A; Shekunova E; Eilbacher B; Bespalov A; Danysz W
    Neuropharmacology; 2006 Dec; 51(7-8):1163-71. PubMed ID: 16926034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioanalytical method for evaluating the pharmacokinetics of the GCP-II inhibitor 2-phosphonomethyl pentanedioic acid (2-PMPA).
    Rais R; Rojas C; Wozniak K; Wu Y; Zhao M; Tsukamoto T; Rudek MA; Slusher BS
    J Pharm Biomed Anal; 2014 Jan; 88():162-9. PubMed ID: 24055700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetylaspartylglutamate (NAAG) is the probable mediator of axon-to-glia signaling in the crayfish medial giant nerve fiber.
    Gafurov B; Urazaev AK; Grossfeld RM; Lieberman EM
    Neuroscience; 2001; 106(1):227-35. PubMed ID: 11564432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of glutamate carboxypeptidase II (NAALADase) protects against dynorphin A-induced ischemic spinal cord injury in rats.
    Long JB; Yourick DL; Slusher BS; Robinson MB; Meyerhoff JL
    Eur J Pharmacol; 2005 Jan; 508(1-3):115-22. PubMed ID: 15680261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection produced by the NAALADase inhibitor 2-PMPA in rat cerebellar neurons.
    Tortella FC; Lin Y; Ved H; Slusher BS; Dave JR
    Eur J Pharmacol; 2000 Aug; 402(1-2):31-7. PubMed ID: 10940354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate carboxypeptidase II (NAALADase) inhibition as a novel therapeutic strategy.
    Thomas AG; Wozniak KM; Tsukamoto T; Calvin D; Wu Y; Rojas C; Vornov J; Slusher BS
    Adv Exp Med Biol; 2006; 576():327-37; discussion 361-3. PubMed ID: 16802724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of GCP-II inhibition on responses of dorsal horn neurones after inflammation and neuropathy: an electrophysiological study in the rat.
    Carpenter KJ; Sen S; Matthews EA; Flatters SL; Wozniak KM; Slusher BS; Dickenson AH
    Neuropeptides; 2003 Oct; 37(5):298-306. PubMed ID: 14607107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice.
    Luszczki JJ; Mohamed M; Czuczwar SJ
    Eur J Pharmacol; 2006 Feb; 531(1-3):66-73. PubMed ID: 16403497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of glutamate carboxypeptidase II hydrolysis of N-acetylaspartylglutamate (NAAG) in crayfish nervous tissue is mediated by glial glutamate and acetylcholine receptors.
    Urazaev AK; Grossfeld RM; Lieberman EM
    J Neurochem; 2005 May; 93(3):605-10. PubMed ID: 15836619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrolysis of the neuropeptide N-acetylaspartylglutamate (NAAG) by cloned human glutamate carboxypeptidase II.
    Luthi-Carter R; Barczak AK; Speno H; Coyle JT
    Brain Res; 1998 Jun; 795(1-2):341-8. PubMed ID: 9622670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.